Live Breaking News & Updates on United States Food And Drug Administration|Page 8

Stay updated with breaking news from United states food and drug administration. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

USFDA resumes inspection of manufacturing plants in India - The Hindu BusinessLine

USFDA resumes inspection of manufacturing plants in India - The Hindu BusinessLine
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Sudarshan Jain , Christopher Middendorf , Michael Kopcha , Indian Pharmaceutical Alliance , United States Food And Drug Administration , Office Of Pharmaceutical Quality , Indian Pharmaceutical Forum , Secretary General , Pharmaceutical Quality , சுதர்ஷன் ஜெயின் , கிறிஸ்டோபர் மீட்தெந்தோர்ப் , மைக்கேல் கோப்சா , இந்தியன் மருந்து கூட்டணி , அலுவலகம் ஆஃப் மருந்து தரம் , இந்தியன் மருந்து மன்றம் , செயலாளர் ஜநரல் , மருந்து தரம் ,

Unichem Labs spurts on USFDA nod for psoriasis drug

Unichem Laboratories surged 5.71% to Rs 323.05 after the company received United States Food and Drug Administration (USFDA) approval for apremilast tablets, 10 mg, 20 mg and 30 mg.
The drug is a generic version of Amgen s Otezla (apremilast) tablets, 10 mg, 20 mg, and 30 mg.
The drug is indicated for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.
The scrip extended gains for third day. The stock has added 6.67% in three sessions from its recent closing low of Rs 302.85 recorded on 16 February 2021.
In the past three months, the stock has added 36.73% while the benchmark Sensex has added 17.55% during the same period. ....

United States , Amgen Otezla , Drug Administration , Unichem Laboratories , United States Food , Capital Market , Branches Of Biology , Mg Cars , Medroxyprogesterone Acetate , Magnesium In Biology , Pharmaceutical Formulations , S Ampp Bse Sensex Index , United States Food And Drug Administration , Severe Plaque , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது மாநிலங்களில் உணவு , மூலதனம் சந்தை , கிளைகள் ஆஃப் உயிரியல் , மிகி கார்கள் , வெளிமம் இல் உயிரியல் , மருந்து சூத்திரங்கள் , கடுமையானது தகடு ,

USFDA: Unichem Laboratories gets USFDA nod for plaque psoriasis treatment drug

Synopsis
Apremilast tablets are indicated for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.
Getty Images
Drug firm Unichem Laboratories on Friday said it has received approval from the US health regulator to market Apremilast tablets, used for treatment of plaque psoriasis.
Apremilast tablets are indicated for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.
The company has received abbreviated new drug application (ANDA) approval to market its Apremilast tablets in the strengths of 10 mg, 20 mg and 30 mg from the United States Food and Drug Administration (USFDA), ....

United States , Amgen Otezla , Drug Administration , Unichem Laboratories , United States Food , Unichem Labs , United States Food And Drug Administration , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது மாநிலங்களில் உணவு ,

Zydus Cadila gets USFDA nod for low blood pressure drug

Zydus Cadila has received final approval from the United States Food and Drug Administration (USFDA) to market Droxidopa capsules in the strength of 100 mg, 200 mg, and 300 mg, Cadila Healthcare said in a regulatory filing. ....

United States , Zydus Cadila , Drug Administration , United States Food , Cadila Healthcare , United States Food And Drug Administration , Low Blood Pressure , ஒன்றுபட்டது மாநிலங்களில் , ஜய்துச் காடிலா , ஒன்றுபட்டது மாநிலங்களில் உணவு , காடிலா சுகாதாரம் , குறைந்த இரத்தம் ப்ரெஶர் ,

US FDA Import Alert takes its toll on Shilpa Medicare

Read more about US FDA Import Alert takes its toll on Shilpa Medicare on Business Standard. Shilpa Medicare slumped 10.88% to Rs 380.25 after the company received an Import Alert from the United States Food and Drug Administration (US FDA), pursuant to its inspection of Unit 4 of the company s Telangana facility. ....

United States , Andhra Pradesh , Drug Administration , Shilpa Medicare , Import Alert , United States Food , Capital Market , United States Public Health Service , Food And Drug Administration , Telangana Facility , United States Food And Drug Administration , ஒன்றுபட்டது மாநிலங்களில் , ஆந்திரா பிரதேஷ் , ஷில்பா மருத்துவ , இறக்குமதி எச்சரிக்கை , ஒன்றுபட்டது மாநிலங்களில் உணவு , மூலதனம் சந்தை , ஒன்றுபட்டது மாநிலங்களில் பொது ஆரோக்கியம் சேவை , தெலுங்கானா வசதி ,